Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1B |
| 2 |
Netflix
NFLX
|
$721M |
| 3 |
Apple
AAPL
|
$468M |
| 4 |
UnitedHealth
UNH
|
$422M |
| 5 |
GE Vernova
GEV
|
$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
$673M |
| 2 |
Robinhood
HOOD
|
$481M |
| 3 |
Meta Platforms (Facebook)
META
|
$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$402M |
| 5 |
Palantir
PLTR
|
$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTNM
3376
Contineum Therapeutics
CTNM
$322M
| $57.2K | ﹤0.01% |
+14,404
| New | +$57.2K |
|
3377
PepGen
PEPG
$45.9M
| $56.9K | ﹤0.01% |
51,300
+6,000
| +13% | +$6.66K |
|
3378
CollPlant Biotechnologies
CLGN
$34.6M
| $56.6K | ﹤0.01% |
41,600
+31,300
| +304% | +$42.6K |
|
3379
Unicycive Therapeutics
UNCY
$77M
| $56.2K | ﹤0.01% |
+11,790
| New | +$56.2K |
|
|
OPI
3380
Office Properties Income Trust
OPI
$16.7M
| $55.5K | ﹤0.01% |
+224,501
| New | +$55.5K |
|
3381
GameSquare
GAME
$68.9M
| $55.1K | ﹤0.01% |
63,400
+36,300
| +134% | +$31.5K |
|
|
ICG
3382
Intchains Group
ICG
$107M
| $55K | ﹤0.01% |
+30,700
| New | +$55K |
|
3383
PharmaCyte Biotech
PMCB
$6.46M
| $54.3K | ﹤0.01% |
49,800
+300
| +0.6% | +$327 |
|
3384
ProPhase Labs
PRPH
$14.7M
| $54K | ﹤0.01% |
137,923
-161,887
| -54% | -$63.3K |
|
3385
enVVeno Medical
NVNO
$14.9M
| $53.9K | ﹤0.01% |
+13,500
| New | +$53.9K |
|
3386
Oblong
OBLG
$6.13M
| $53.7K | ﹤0.01% |
+14,394
| New | +$53.7K |
|
3387
Inspirato
ISPO
$39.4M
| $52.6K | ﹤0.01% |
+15,435
| New | +$52.6K |
|
3388
Stagwell
STGW
$1.44B
| $51.8K | ﹤0.01% |
+11,500
| New | +$51.8K |
|
3389
Rafael Holdings
RFL
$50.5M
| $51.6K | ﹤0.01% |
29,831
+1,103
| +4% | +$1.91K |
|
3390
ICZOOM Group
IZM
$29.3M
| $51.2K | ﹤0.01% |
+18,837
| New | +$51.2K |
|
3391
Sonoma Pharmaceuticals
SNOA
$7.77M
| $50.6K | ﹤0.01% |
+17,800
| New | +$50.6K |
|
3392
Opko Health
OPK
$1.07B
| $50.3K | ﹤0.01% |
+38,100
| New | +$50.3K |
|
3393
Galecto
GLTO
$3.99M
| $49.6K | ﹤0.01% |
14,544
-800
| -5% | -$2.73K |
|
3394
FAT Brands
FAT
$33.6M
| $49.5K | ﹤0.01% |
20,800
-1,300
| -6% | -$3.09K |
|
|
AACG
3395
ATA Creativity
AACG
$64.5M
| $49.3K | ﹤0.01% |
64,044
-400
| -0.6% | -$308 |
|
|
KNDI
3396
Kandi Technologies Group
KNDI
$114M
| $48.6K | ﹤0.01% |
43,800
-800
| -2% | -$888 |
|
3397
Smith Micro Software
SMSI
$15.5M
| $48.1K | ﹤0.01% |
55,841
-1,200
| -2% | -$1.03K |
|
3398
Titan Pharmaceuticals
TTNP
$5.63M
| $47.8K | ﹤0.01% |
+11,380
| New | +$47.8K |
|
3399
OLB
OLB
$9.82M
| $47.2K | ﹤0.01% |
+25,260
| New | +$47.2K |
|
3400
Dyadic International
DYAI
$32.9M
| $47.1K | ﹤0.01% |
47,605
+16,629
| +54% | +$16.5K |
|